MicroRNA for the early detection of type 2 diabetes mellitus: literature review
DOI:
https://doi.org/10.56294/saludcyt2023507Keywords:
Micrornas, Biomarkers, Type 2 Diabetes Mellitus, Insulin Resistance, Early DetectionAbstract
Introduction: Diabetes Mellitus (DM) is a glucose metabolism disorder of multiple etiology, representing more than 90 % of diabetes cases around the world. Current studies have proposed microRNAs (miRNAs) as possible early biomarkers of the disease.
Objective: review the literature on the use of miRNAs as biomarkers in the early detection of type 2 Diabetes Mellitus (T2DM).
Methods: comprehensive searches of scientific databases were carried out and nine studies that met the inclusion criteria were selected. These studies examined the expression profiles of specific miRNAs and their utility as diagnostic and prognostic markers.
Results: they revealed that certain miRNAs, such as miR-21, miR-122, miR-148b-3p, miR-27a-3p and miR-135, showed significant changes in their expression in patients with T2DM and prediabetes compared to healthy individuals. These miRNAs were also associated with key metabolic processes, such as the regulation of insulin signaling, insulin resistance, and inflammation.
Conclusions: these findings support the potential of miRNAs as biomarkers for early detection, prognosis, and management of T2DM and prediabetes. However, further research is required to validate and better understand the clinical relevance of miRNAs in these metabolic diseases
References
1. Association AD. Standards of Care in Diabetes - 2023. Diabetes journals 2023;46:1-298.
2. Webber S. International Diabetes Federation. vol. 102. 2021. https://doi.org/10.1016/j.diabres.2013.10.013.
3. Vasu S, Kumano K, Darden CM, Rahman I, Lawrence MC, Naziruddin B. MicroRNA signatures as future biomarkers for diagnosis of diabetes states. Cells 2019;8:1-32. https://doi.org/10.3390/cells8121533.
4. Wanken ZJ, Anderson PB, Bessen SY, Rode JB, Columbo JA, Trooboff SW, et al. The Profiling and Role of miRNAs in Diabetes Mellitus. J Hosp Med 2020;72:286-92. https://doi.org/10.33696/diabetes.1.003.The.
5. Jiménez-Lucena R, Camargo A, Alcalá-Diaz JF, Romero-Baldonado C, Luque RM, van Ommen B, et al. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study. Experimental and Molecular Medicine 2018;50. https://doi.org/10.1038/s12276-018-0194-y.
6. La Sala L, Mrakic-Sposta S, Tagliabue E, Prattichizzo F, Micheloni S, Sangalli E, et al. Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D. Cardiovascular Diabetology 2019;18:1-12. https://doi.org/10.1186/s12933-019-0824-2.
7. Ghai V, Baxter D, Wu X, Kim TK, Kuusisto J, Laakso M, et al. Circulating RNAs as predictive markers for the progression of type 2 diabetes. Journal of Cellular and Molecular Medicine 2019;23:2753-68. https://doi.org/10.1111/jcmm.14182.
8. Feng T, Li K, Zheng P, Wang Y, Lv Y, Shen L, et al. Weighted Gene Coexpression Network Analysis Identified MicroRNA Coexpression Modules and Related Pathways in Type 2 Diabetes Mellitus. Oxidative Medicine and Cellular Longevity 2019;2019. https://doi.org/10.1155/2019/9567641.
9. Ghoreishi E, Shahrokhi SZ, Kazerouni F, Rahimipour A. can be potential biomarkers for diagnosis of pre ‑ diabetes and type 2 diabetes : integrating experimental and in ‑ silico approaches. BMC Endocrine Disorders 2022:1-10. https://doi.org/10.1186/s12902-022-01120-5.
10. Ramanjaneya M, Priyanka R, Bensila M, Jerobin J, Pawar K, Sathyapalan T, et al. MiRNA and associated inflammatory changes from baseline to hypoglycemia in type 2 diabetes. Frontiers in Endocrinology 2022;13:1-10. https://doi.org/10.3389/fendo.2022.917041.
11. Zeinali F, Zarch SMA, Jahan-Mihan A, Kalantar SM, Mehrjardi MYV, Fallahzadeh H, et al. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study. PLoS ONE 2021;16:1-13. https://doi.org/10.1371/journal.pone.0251697.
12. Yazdanpanah Z, Kazemipour N, Kalantar SM, Vahidi Mehrjardi MY. Plasma miR-21 as a potential predictor in prediabetic individuals with a positive family history of type 2 diabetes mellitus. Physiological Reports 2022;10:1-9. https://doi.org/10.14814/phy2.15163.
13. Monfared YK, Honardoost M, Sarookhani MR, Farzam SA. Circulating miR-135 May Serve as a Novel Co-biomarker of HbA1c in Type 2 Diabetes. Applied Biochemistry and Biotechnology 2020;191:623-30. https://doi.org/10.1007/s12010-019-03163-2
Published
Issue
Section
License
Copyright (c) 2023 Joselyn Lissette Martínez Altamirano , Ángel Geovanny Romo López (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
